Naturally Splendid (TSXV:NSP) has provided the following update on its proprietary omega encapsulation technology HempOmega and the addition of Kelley Fitzpatrick to the advisory board.
Since Naturally Splendid commercialized its first version of HempOmega(TM) in late 2015, the Company has been developing advancing formulations of its Omega encapsulation technology with it’s R&D partner POS-Bio Sciences. The technology has proven to be feasible and economical for multiple applications. This includes the recent Dog Food trials as per the recently announced Canature Processing Ltd. agreement to create HempOmega(TM) infused dog food and treats.
Naturally Splendid HempOmega(TM) updates:
We are pleased to announce that we have created several new versions of HempOmega(TM) for various applications:
HempOmega(TM) Beverages – With the cooperation of Dr. Rick Green, VP of Technology at POS Biosciences, NSE was able to fortify a juice beverage with HempOmega(TM) that delivered a plant based omega formulation solution for the beverage industry. The process incorporated encapsulated materials to inhibit oil oxidation while providing your daily dose of omega nutrition.
HempOmega(TM) Flavored Protein Blends – Naturally Splendid has formulated HempOmega(TM) into two hemp protein powder blends, Isodiol’s IsoSport Pro369 which features four flavours; Vanilla Caramel, Banana Chocolate, Mixed Berry and Tropical Powder – that received Natural Product Numbers “(NPN)”from Health Canada. NSE recently launched its own HempOmega(TM) infused hemp protein drink, NATERAtrademark Hemp Protein 369 at the recent Canadian Health Food Tradeshow “(CHTA)” in Vancouver, Canada.
HempOmega(TM) Bakery – Naturally Splendid along with the Saskatoon Food and Development Centre, was able to create a successful unleavened bread product that incorporated HempOmega(TM). This HempOmega(TM) version provides a solution to the frozen pizza, flat bread industry to incorporate plant based omegas as an ingredient into their products.
HempOmega(TM) Pet Food – Working with the Alberta Food Development Centre, NSE created a nutritious pet food (dry kibble for dogs) that incorporated HempOmega(TM). Our technology resolved the loss of lipids in the extrusion process. Testing conducted on the pet food prototypes demonstrated the profile for ALA, GLA, SDA from HempOmega(TM) survived the rigorus heat intensive manufacturing process. This demonstrated that HempOmega(TM) is suitable for pet food applications.
Read full company profile.
HempOmega(TM) Livestock Feed – Animal studies were conducted at the university of Manitoba with the cooperation of Dr. James House, which demonstrated improved efficacy and bio availability for both broilers and layers. The thigh meat of the broilers and the eggs of the layers were analyzed and showed higher expression of omegas versus “normal” feeding methods.
HempOmega(TM) Cosmetics – Naturally Splendid worked with Dr. Jeremy from the USA to create a topical solution that addressed anti-inflammation and joint pain by combining HempOmega(TM) with CBD. The antidotal feedback from Dr. Jeremy and his team was the immediate relief of joint pain.
HempOmega(TM) Emulsion and Powder – The emulsion is the liquid precursor to the powdered version. The HempOmega(TM) powder increases the range of uses and applications depending on the manufacturing processes. Both the emulsion and the powder are commercially scalable and approved for animal and human consumption
All of these versions are designed to be tailored to the specific needs of the product. NSE will continue its development of HempOmega(TM) for other markets.
Naturally Splendid CEO Dave Eto States,” These versions of HempOmega(TM) technology represent the initial stages of the many possible applications that are yet to be discovered. As mentioned in previous news releases our IsoSport Pro369trademark formulation and new Canture pet food and treat products are an example of HempOmega(TM) applications.
While our current main focus is with hemp, it is important to understand that our omega encapsulation technology is not limited to hemp oil, but is in fact, applicable to any plant-based omega oils such as flax, chia and algae to name a few. We are in discussions with multiple companies covering the fore mentioned versions of HempOmega(TM) and I look forward to sharing our progress as these discussion mature.
Kelley C. Fitzpatrick is the president of NutriScience Solutions, Inc., a Manitoba based consulting firm. Kelley is a well-recognized expert in numerous areas of Canadian agriculture, health, regulatory and government affairs. Kelley provides a unique and comprehensive perspective on the agriculture and health sector in Canada, having worked with all stakeholders including government, private industry, research, trade associations and as an entrepreneur.
With over 25 years of experience, Kelley possesses extensive scientific, regulatory, promotion, marketing and management experience. She is a versatile professional with diverse leadership experience, association management expertise and business acumen. Kelley is an exceptional communicator, a respected and reliable industry representative, and an expert resource for private companies. Kelley is well-versed in board facilitation, governance and operation.
Kelley’s knowledge of scientific and marketing strategies, competitive assessment reports, business planning, research and sales support has assisted numerous stakeholders of novel food ingredients to introduce products to international food companies throughout the agriculture and food value-chain. Ms. Fitzpatrick has a Master of Science degree in Nutrition from the University of Manitoba and a Bachelor of Arts degree from the University of Winnipeg.
Company CEO Dave Eto summarizes, “It is with great pleasure that I welcome Kelley to our Advisory Board. Kelley was involved in preparing the initial Market Study on HempOmega(TM) for Naturally Splendid. Kelley is very knowledgeable of our proprietary omega encapsulation technology. Her years of experience in the agriculture and health sectors will be of great benefit in our efforts to further commercialize our Omega technologies”.
About Naturally Splendid Enterprises Ltd.
Naturally Splendid is a multifaceted biotechnology company that is developing, producing, commercializing, and licensing an entirely new generation of plant-derived, bioactive ingredients, nutrient dense foods, and related products. Naturally Splendid is building an expanding portfolio of patents (issued and pending) and proprietary intellectual property focused on the commercial uses of industrial hemp and non-psychoactive cannabinoid compounds in a broad spectrum of applications.

Forward-Looking Statements
Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management’s current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. Naturally Splendid cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond Naturally Splendid’s control including, the Naturally Splendid’s ability to compete with large food and beverage companies; sales of any potential products developed will be profitable; sales of shelled hemp seed will continue at existing rates or increase; the ability to complete the sales of all bulk hemp seed purchase orders; and the risk that any of the potential applications may not receive all required regulatory or legal approval. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward looking information. Except as required under applicable securities legislation, Naturally Splendid undertakes no obligation to publicly update or revise forward-looking information.

Click here to connect with Naturally Splendid (TSXV:NSP) to receive an Investor Presentation.


Cannabis Market Update: Q3 2020 in Review

Click here to read the previous cannabis market update.

During the first few months of investment time in 2021, cannabis faced some volatility alongside optimism about federal changes in the most important market for the drug.

The cannabis business found its stride during Q1 thanks to policy change signals and consolidation.

To find out more, the Investing News Network (INN) asked experts about progress in the market during the first major period of the new year, and which developments investors should watch out for.


Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

Cannabis market update: New York and US potential boost operations

New York state’s legalization of recreational cannabis was a huge Q1 announcement that added pressure to the US federal government when it comes to cannabis policy, said George Mancheril, co-founder and CEO of Bespoke Financial, a debt financing business with a particular focus on servicing cannabis businesses.

“It’s going to add to the chorus of voices in the federal scene to basically move sooner rather than later,” he explained to INN.

Following the US election in 2020, the momentum for cannabis businesses went on the upswing, as did company valuations, with the idea of expansion at the heart of it all, according to Mancheril.

Before starting Bespoke Financial, Mancheril learned from traditional investment banks, working in the lending, fixed income and debt markets with Goldman Sachs (NYSE:GS) and Guggenheim Partners.

Nawan Butt, portfolio manager with Purpose Investments, agrees with Mancheril. The financial expert told INN the ongoing legalization process seen in the US market is leading to expansion.

“It’s becoming more of a national move, then small pockets of proliferation. That’s very exciting about cannabis right now,” said Butt, who co-manages the Purpose Marijuana Opportunities Fund (NEO:MJJ).

This proliferation effect is causing a change in valuations and enthusiasm for US-based operations. Mancheril told INN that by the end of Q1, multi-state operators (MSOs) had raised approximately US$3.3 billion.

The cannabis lender said he sees the industry as having grown from the woes of 2019; it is now undergoing a return to form as excitement about the US opening up increases.

The expert explained that there is likely to be a windfall of capital in the wake of major federal changes in US cannabis policy, although the timeline for these changes is becoming increasingly hard to predict.

Leading up to that capital influx, Mancheril said he wants to see operators really drill down on the value of desired assets and whether they make sense.

“What I’d hope is that we continue to see bullish sentiment, but with some measure of responsibility, and let’s not just get over ahead of ourselves,” Mancheril told INN. “The idea is let’s minimize the volatility and continue growing responsibly.”


Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

As far as struggles go, Butt explained that the cannabis industry has cemented itself as a growth-type sector, and as such there are macro pressures affecting the way these assets operate.

“We’ve seen this preference for cash flows at growth in the current or in the near future, rather than in the far future, and that’s what we’re seeing as far as valuations go in the broad market,” Butt said.

Cannabis market update: Volatility continues to rule as industry foundations build

Despite the industry’s potential and the growing pains it has gone through as a whole in both the US and Canada, volatility remains a key factor in the cannabis investment scene.

Butt explained that the current shareholder base, which is dominated by hedge funds and retail investors, still lacks enough institutional support to avoid the day-to-day volatility cannabis has come to be known for.

These two investor groups, Butt said, can be easily spooked and excited by the news of the day when it comes to their investments.

“A lot of these institutions’ strategies are not about short-term profits, but they’re about long-term sustainability of the businesses themselves,” Butt said.

“That’s why you see a lot of volatility in the space, and that’s essentially what we’ve seen over the past, I’d say, three to two months as well,” he added.

That means investors shouldn’t expect an end to volatility anytime soon.

“It’s not about whether we continue to expect volatility, because we do,” Butt said. “We really think that the volatility will be taken out when the shareholder base becomes more institutional, but it’s really about understanding why there is volatility in the first place.”

Cannabis market update: Canadians talk up US business, but questions remain

A surge of mergers and acquisitions has taken over the Canadian cannabis sector recently as more producers see potential in America.

One of the biggest announcements in this regard came when Organigram Holdings (NASDAQ:OGI,TSX:OGI) secured a C$221 million investment deal from British American Tobacco (NYSE:BTI,LSE:BATS).

Using the funds, the two will work in tandem to develop new branded products designed for the international stage, including in the US. Organigram CEO Greg Engel previously told INN that the US represents a critical opportunity for Canadian companies, but the entry point isn’t as clean as it could be.


Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

While the long-term potential may be exciting for investors, Butt told INN he’s still unsure how the approach will work for Canadian companies.

The Purpose Investments expert said there will be plenty of space for the biggest Canadian names to pursue US market entries, beyond the initial hemp-derived CBD moves some operators have mde, since the US represents the biggest market in the world.

“But there’s just way too many unknowns right now to say exactly what that participation is going to look like, or when that participation will happen,” he said.

“What we do know is that currently the US MSOs are in a wonderful sort of position to expand on their market leadership that they have. And it will be tough for Canadians to come in and compete with them,” Butt said.

Canadian players still retain the upper hand at times in terms of valuation, which is confusing for both Butt and Dan Ahrens, chief operating officer and portfolio manager at AdvisorShares.

“The performance in quarterly earnings of US companies has been rather spectacular. They’ve knocked it out of the park in most instances,” Ahrens told INN.

Butt praised the recent performance reports from MSOs across the board, pointing to year-over-year growth lines and projections for continued positive performance. In his view, share prices still don’t reflect company value. “Those are really being discounted at this point,” Butt told INN.

“We’ve seen the Canadian licensed producers be really hot stock performance-wise, outpacing the US (MSOs), and I’ll say it’s rather nonsensical to me,” said Ahrens, who oversees the AdvisorShares Pure Cannabis ETF (ARCA:YOLO) and the recently launched AdvisorShares Pure US Cannabis ETF (ARCA:MSOS).

Cannabis market update: Investor takeaway

The cannabis investment proposition finds itself at an interesting moment in time, as the entire sector eagerly awaits confirmation in the US at the federal level.

While for the Canadian companies waiting on the sidelines, this development may feel like a major necessity to address current financial struggles, for US-based operators, the heat around the corner could represent future positivity for already thriving operations.

Keep reading... Show less

 Trulieve Cannabis Corp. (“Trulieve” or the “Company”) (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States will release its first quarter 2021 financial results on Thursday, May 13, 2021 before markets open. Following the earnings release, management will host a conference call at 8:30 AM Eastern Time to review the financial results.

All interested parties can join the conference call by dialing 1-888-231-8191 or 1-647-427-7450, conference ID: 4880609. Please dial in 15 minutes prior to the call to secure a line. The conference call will be archived for replay until May 20, 2021 . To access the archived conference call, please dial 1-855-859-2056 and enter the encore code 4880609.

Keep reading... Show less

Appointment of Dr. Kelmendi, Assistant Professor of Psychiatry at Yale University and co-founder of the Yale Psychedelic Science Group, brings another experienced medical professional to Lobe’s advisory team.

 Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) is pleased to announce the appointment of Benjamin Kelmendi, MD, Assistant Professor of Psychiatry at Yale University School of Medicine, to its Scientific Advisory Board.

Keep reading... Show less

Ayurcann Holdings Corp. ( CSE: AYUR ) (the “ Company ” or ” Ayurcann “), a Canadian extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative products, is pleased to unveil further details of its Phase 2 expansion plans.

Ayurcann has commenced trading on the Canadian Securities Exchange (” CSE “) on April 8, 2021 and subsequently announced a private placement of up to $500,000 (” Financing “), as per the Company’s press release dated April 12, 2021. The proceeds of the Financing are intended to be used to further pursue Phase 2 of the expansion of the production capacity of the Company’s Pickering facility.

Keep reading... Show less